Replies to post #109749 on Biotech Values

[zipjet]

I'm not exactly sure how TEVA defends the suit without putting their capabilities in the public domain.

The court will use protective orders to manage this type of information. It will never be public via this suit.

[stockbettor]

Sandoz a co-plaintiff

Although not mentioned in Momenta's PR, Sandoz is also a plaintiff:

COMPLAINT

INTRODUCTION

Plaintiffs Momenta Pharmaceuticals, Inc. (“Momenta”) and Sandoz Inc. (“Sandoz”),
bring this action for patent infringement and declaratory judgment against defendants Teva
Pharmaceuticals Industries, Ltd and Teva Pharmaceuticals USA, Inc. (collectively, “Teva”).
Plaintiffs seek judgment that certain methods used by the defendants when making an
enoxaparin drug product have infringed and/or will infringe United States Patent Nos. 7,575,886
(the “'886 patent”) and 7,790,466 (the “'466 patent”).

[Jonathan Robinson]

Devil's advocate - could also mean that MNTA has gotten word through grapevine that approval for Teva is imminent.

Jon